Lawyers, worried about the recent study suggesting how attractive people can sway juries? What if the physician-defendant you're cross-examining is too attractive for your liking?

No fear, here's how to overcome this.

In the DEA's fight against chronic pain treatment, patients are often the losers:

"Doctors are trained to treat patients, not to be detectives," says Dr. James N. Campbell, a Johns Hopkins University neurosurgeon specializing in pain, who will be another witness for Dr. Hurwitz. He says that doctors have already reacted to the D.E.A. crackdown by changing the way they deal with the many Americans "” at least 50 ...

Read more...

A story from the Washington Post about the ambiguity of mammogram readings. "Wait and see", or the conservative, evidence-based approach, clearly is taking a hit in this piece. A breast MRI to confirm an ultimately harmless finding is demanded by the patient.

Essays like this, which perpetuate the falsehood that more testing equals better medicine, simply serve to further drive up health care costs. (via ...

Read more...

Vision problems forced the career change - but his malpractice history, and Google, is scaring off potential spa clients.

Cardiologist Dr. Wes looks at the real-world implications. Bob Centor also chimes in. Here's what the NEJM thinks.

Combine high cost of living with this, and no wonder they're having trouble recruiting:

Massachusetts continues to decline as a place to practice medicine, the Massachusetts Medical Society reports today. The deteriorating environment has led to a shortage of physicians and reduced access to care that are a cause for concern as the state implements its new healthcare law, the group warns. . .

. . . Low ...

Read more...

Life as a drug rep ain't what it used to be:

Doctors seem to be getting fed up with the reps, said Andrew Brana from the sales research firm TNS. Fifty-one percent of doctors responding to a survey complained about "over-aggressive sales practices," said Brana, while 87 percent of drug companies say they're taking a "smarter" approach towards wooing physicians, primarily by trying to understand what medications specific doctors ...

Read more...

Schwitzer seems to think so:

In today's WSJ, the front page of the "Marketplace" section, page B1, has a story on the "blockbuster drug plavix" and a pack of new rivals on the horizon.

But negative findings on two other drug studies are relegated to pages B6 and B7, deep in the paper and deeper in that section.

Stents take a hit

From the ACC meetings, the results that were supposed to be released tomorrow were leaked early:

For patients with stable coronary artery disease, treatment with angioplasty and bare-metal stents does not reduce the risk of heart attack or a composite of death, heart attack and stroke.
Let's see if this study will change medical practice or not. Stent supporters are on the defense:
The key quote about Courage ...

Read more...

In these trying times for the Edwards' family, Adam Hanft wonders if John Edwards' past as a malpractice attorney has helped create an environment that forces physicians to practice less than ideal care:

The media has covered the Edwards' story in terms of the painful decision they faced about whether or not to continue the campaign. But conspicuously absent has been any real attention paid to the relationship between ...

Read more...

Believe it or not, there is a bill in Massachusetts suggesting just a thing. A plaintiff malpractice lawyer's dream? Surprisingly, they are against the idea as well.

Well, when you look at the reimbursement patterns, this is no surprise:

"Typically, people will spend between $300 and $1,000 for a Botox treatment," says Resneck, all of which is paid for by the patient (given it's for cosmetic reasons), usually at the time of service. By comparison, a skin checkup might net a dermatologist an eventual insurance payment of anywhere from $30 to $100.

Does it make a difference? A study present at the ACC Meetings suggest so:

Female physicians are better than men in treating fellow women with high-blood pressure and cholesterol, and they also are better at helping men control cholesterol, the Swedish study found . . .

. . . One reason for the better cholesterol-control may be that the women doctors studied were more likely to prescribe lipid-lowering ...

Read more...

Death favors the insurance companies - why health insurers drag their feet on paying elderly policyholders.

It's no secret that the financial burden is weighing heavily on the minds of medical students and residents:

Kaufman said that physician pay, while good compared with other professions, varies by regions. He recently saw a job posting in the Midwest that would double his salary. Medical students with hundreds of thousands of dollars of debt gravitate toward places like that in order to survive. The physician climate in ...

Read more...

It has been removed from the bill, for now. This ridiculous idea has been hashed out in a previous post.

Finding a doctor that accepts Medicare is getting increasingly difficult - a situation that will only worsen:

"One of the main culprits is the 'overpromise/underfund' dilemma of offering public health-care programs such as Medicaid (for the poor and disabled) and Medicare (for people 65 and over) without sufficient funding, then standing back as demand skyrockets."

As with most things in life, it gets down to dollars. Operating a physician ...

Read more...

Scott Gottlieb wonders whether her treatment would have been as aggressive:

While recent trends in cancer survival cannot be ascribed to the new drugs alone, it is undeniable that more effective, less toxic medicines are having real impact.

Yet these improvements are not being realized around the world. Europe should be sharing in the progress against cancer, but large bureaucracies have been erected to contain costs, by slowing ...

Read more...

The WSJ reports the findings of this once-promising drug from the ACC meetings:

This morning the curtain was pulled back on study results the company had hoped would support its eventual approval. The experimental drug raised patients' good cholesterol by 61% when taken with Lipitor, compared with those taking Lipitor alone. But that increase in good cholesterol didn't halt or reverse narrowing of arteries, a disappointment that casts doubt ...

Read more...

Dr. Wes says that as doctors practice more at satellite offices, patients are increasingly being seen by their colleagues.

Of course, the concept of interchangeable doctors is already in full force with the hospitalist movement.

Most Popular